Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial.
OBJECTIVE
Infections with Trichomonas vaginalis (TV) are common and recurrence rates are high. Better methods of treating partners of women with trichomoniasis are needed.


OBJECTIVE
To determine if patient-delivered partner treatment (PDPT) is better and more cost-effective than partner referral.


METHODS
Women attending a family planning clinic who were culture-positive and treated for TV (N = 463) were randomized to either standard partner referral (PR), booklet-enhanced partner referral (BEPR), or PDPT. At baseline and 1 month, women were interviewed and cultured for TV. Detailed cost information was also collected.


RESULTS
Most women had 1 partner, were less than 24 years old, and were black. The percentage of women reporting that their partners were treated was similar for PDPT but significantly lower for BEPR compared to PR. TV follow-up rates were similar. PDPT cost less and was cost saving compared to PR and BEPR.


CONCLUSIONS
Among women with TV, PDPT did not result in more partners taking the medicine or lower follow-up rates than PR but was less costly.
Tulane University Health Sciences Center, School of Public Health and Tropical Medicine, New Orleans, Louisiana 70012, USA. kissing@tulane.edu
Patricia
P
Kissinger
Norine
N
Schmidt
Hamish
H
Mohammed
Jami S
JS
Leichliter
Thomas L
TL
Gift
Bernadette
B
Meadors
Cheryl
C
Sanders
Thomas A
TA
Farley
D000328:Adult; D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008145:Louisiana; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage*; D011314:Preventive Health Services / Q000191:economics*; D012017:Referral and Consultation; D012747:Sexual Partners; D016896:Treatment Outcome; D014247:Trichomonas Vaginitis / Q000517:prevention & control*; D014246:Trichomonas vaginalis
D000981:Antiprotozoal Agents; D008795:Metronidazole